MARKET COMPOSITE
CWEB - Direxion Shares ETF Trust9:00:00 PM 2/20/2024
Price
$27.68
-0.91 (-3.18%)
The investment seeks daily investment results, of 200% of the daily performance of the CSI Overseas China Internet Index. The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments, such as swap agreements, and securities of the index, ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index is designed to measure the performance of the investable universe of publicly traded China-based companies whose primary business or businesses are in the Internet and Internet-related sectors. It is non-diversified.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news

    Charlotte’s Web Holdings Inc. (CWBHF) (CA:CWEB) shares are rallying by nearly 23% after the company said it inked an exclusive, multi-year partnership with Major League Baseball to become the first official CBD in the sport. Major League Baseball also marks the first major professional sports league to form a sponsorship agreement with a CBD company, Charlotte’s Web said. Charlotte’s Web products which receive the NSF Certified for Sport designation of safety standards and are cleared for p...

    Direxion (www.direxion.com) has announced it will execute a reverse split of the issued and outstanding shares of the Direxion Daily Energy Bear 2X Shares (Ticker: ERY), Direxion Daily CSI China Internet Index Bull 2X Shares (Ticker: CWEB), and the Direxion Daily FTSE China Bull 3X Shares (Ticker: YINN) (each, a "Fund" and collectively, the "Funds"). The total market value of the shares outstanding will not be affected as a result of these splits, except with respect to the redemption of fractio

    (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc., ("Charlotte's Web" or the "Company"), the market leader in full-spectrum cannabidiol ("CBD") hemp extract wellness products, has achieved a milestone becoming one of the first companies to receive validation of its Novel Food applications from the UK Food Standards Agency ("FSA") for its full-spectrum hemp extracts in the United Kingdom. To date, most UK consumers have had access primarily to CBD isolate products and may be unaware of th

    (TSX: CWEB) (OTCQX: CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the fourth quarter and year ended December 31, 2021.

    (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc., ("Charlotte's Web" or the "Company"), the market leader in cannabidiol ("CBD") hemp extract wellness products, has signed an exclusive product distribution agreement in the United Kingdom with Savage Cabbage Ltd., one of the oldest and most trusted CBD companies in the UK, serving an active and loyal customer base of wellness seekers.

    Last week witnessed a tug-of-war between bulls and bears.

    Charlotte's Web Holdings Inc. launched a C$67.5 million ($49.9 million) offering of shares through syndication on Tuesday, joining the many companies to issue new equity during the coronavirus pandemic. The Boulder, Colo.-based maker of CBD and hemp extract products said Cannacord will serve as lead underwriter with Cormark Securities, Eight Capital and PI Financial acting as co-managers. U.S.-listed share fell 11% and are down 38% in the year to date, while the S&P 500 has fallen 5%.

    Charlotte's Web Holdings Inc. said Tuesday that it will sponsor ValidCare along with six other CBD brands in conducting a human trial to determine whether daily CBD use has any impact on the liver. ValidCare is a clinical trial outsourcing company. In a statement, the Boulder, Colorado-based company said the study is a response to Food and Drug Administration's public questions about CBD products and how they impact the human liver. "As the market share leader, anchored in science, sponsoring V...

    Inside the top-and-worst-performing leveraged ETFs of last week.

    Prices of the nonintoxicating variety of cannabis have continued to fall, tripped up by regulatory issues. CBD may get hot again, but that won’t help farmers sitting on piles of last year’s hemp biomass